Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.

[1]  M. Porta,et al.  Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose , 2004, Diabetes/metabolism research and reviews.

[2]  S. Yamagishi,et al.  Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells. , 2003, Kidney international.

[3]  T. Jomori,et al.  Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes. , 2002, Biochemical and biophysical research communications.

[4]  Masayoshi Takeuchi,et al.  Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  H. Hammes.  Pericytes and the pathogenesis of diabetic retinopathy. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[6]  D. Bonnefont-Rousselot.  Glucose and reactive oxygen species , 2002, Current opinion in clinical nutrition and metabolic care.

[7]  Z. Makita,et al.  Beraprost Sodium, a Prostaglandin I2 Analogue, Protects Against Advanced Glycation End Products-induced Injury in Cultured Retinal Pericytes , 2002, Molecular medicine.

[8]  Z. Makita,et al.  Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties. , 2002, Biochemical and biophysical research communications.

[9]  Z. Makita,et al.  Advanced Glycation End Product-induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor and Monocyte Chemoattractant Protein-1 in Human-cultured Mesangial Cells* , 2002, The Journal of Biological Chemistry.

[10]  S. Bursell,et al.  Suppression of diabetic retinopathy with angiopoietin-1. , 2002, The American journal of pathology.

[11]  Z. Makita,et al.  Palmitate-Induced Apoptosis of Microvascular Endothelial Cells and Pericytes , 2002, Molecular medicine.

[12]  W. Graier,et al.  Vascular targets of redox signalling in diabetes mellitus , 2002, Diabetologia.

[13]  A. Adamis,et al.  Vascular endothelial growth factor gene regulation and action in diabetic retinopathy. , 2002, Ophthalmology clinics of North America.

[14]  Peter Gehlbach,et al.  Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. , 2002, Investigative ophthalmology & visual science.

[15]  K. Davies,et al.  Calcium and oxidative stress: from cell signaling to cell death. , 2002, Molecular immunology.

[16]  Hiroshi Yamamoto,et al.  Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes. , 2002, Biochemical and biophysical research communications.

[17]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[18]  H. Hammes,et al.  Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. , 2001, Diabetes.

[19]  X. Lei,et al.  Comparative impacts of glutathione peroxidase-1 gene knockout on oxidative stress induced by reactive oxygen and nitrogen species in mouse hepatocytes. , 2001, The Biochemical journal.

[20]  M. Mirault,et al.  Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. , 2001, Molecular pharmacology.

[21]  M. Brownlee,et al.  Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. , 2001, Diabetes.

[22]  K. Alitalo,et al.  Tie receptors: new modulators of angiogenic and lymphangiogenic responses , 2001, Nature Reviews Molecular Cell Biology.

[23]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[24]  John Calvin Reed,et al.  Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. , 2000, The American journal of pathology.

[25]  W. Benedict,et al.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.

[26]  K. Suzuma,et al.  Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells* , 1999, The Journal of Biological Chemistry.

[27]  Hiroshi Yamamoto,et al.  Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[28]  H. Jaeschke,et al.  Glutathione peroxidase–deficient mice are more susceptible to neutrophil‐mediated hepatic parenchymal cell injury during endotoxemia: importance of an intracellular oxidant stress , 1999, Hepatology.

[29]  H. Augustin,et al.  Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[30]  Hiroshi Yamamoto,et al.  Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells , 1998, Diabetologia.

[31]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[32]  E. Keshet,et al.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.

[33]  G. Cockerell,et al.  Increased ratio of bcl-2/bax expression is associated with bovine leukemia virus-induced leukemogenesis in cattle. , 1998, Virology.

[34]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[35]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[36]  Hiroshi Yamamoto,et al.  Advanced Glycation End Products-driven Angiogenesis in Vitro , 1997, The Journal of Biological Chemistry.

[37]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[38]  J. Folkman,et al.  Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.

[39]  Hiroshi Yamamoto,et al.  Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin‐producing ability of endothelial cells through interactions with their receptors , 1996, FEBS letters.

[40]  Yasuhiko Hayashi,et al.  Possible Participation of Autocrine and Paracrine Vascular Endothelial Growth Factors in Hypoxia-induced Proliferation of Endothelial Cells and Pericytes (*) , 1995, The Journal of Biological Chemistry.

[41]  H. Yamamoto,et al.  Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy. , 1995, Biochemical and biophysical research communications.

[42]  G. Chader,et al.  Identification of pigment epithelium-derived factor in the interphotoreceptor matrix of bovine eyes. , 1995, Protein expression and purification.

[43]  J. Cidlowski,et al.  Apoptosis: the biochemistry and molecular biology of programmed cell death. , 1993, Endocrine reviews.

[44]  H. Yamamoto,et al.  Endothelin 1 mediates endothelial cell-dependent proliferation of vascular pericytes. , 1993, Biochemical and biophysical research communications.

[45]  G. Chader,et al.  Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  H. Yamamoto,et al.  Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells. , 1993, Biochemical and biophysical research communications.

[47]  J. Tombran-Tink,et al.  PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. , 1991, Experimental eye research.

[48]  J. Tainer,et al.  Selenocysteine's mechanism of incorporation and evolution revealed in cDNAs of three glutathione peroxidases. , 1988, Protein engineering.

[49]  D TOUSSAINT,et al.  Retinal vascular patterns. IV. Diabetic retinopathy. , 1961, Archives of ophthalmology.

[50]  S. Yamagishi,et al.  Angiotensin II-type 1 receptor interaction upregulates vascular endothelial growth factor messenger RNA levels in retinal pericytes through intracellular reactive oxygen species generation. , 2003, Drugs under experimental and clinical research.

[51]  S. Yamagishi,et al.  Up-regulation of vascular endothelial growth factor and down-regulation of pigment epithelium-derived factor messenger ribonucleic acid levels in leptin-exposed cultured retinal pericytes. , 2002, International journal of tissue reactions.

[52]  S. P. Becerra.  Structure-Function Studies on PEDF , 1997 .

[53]  Becerra Sp.  STRUCTURE-FUNCTION STUDIES ON PEDF A Noninhibitory Serpin with Neurotrophic Activity , 1997 .